BiotechTube
Home/Galderma/Michele Libonati
ML

Michele Libonati

Chief Operating Officer

Galderma

Therapeutic Areas

DermatologyAesthetic Medicine

Galderma Pipeline

DrugIndicationPhase
Twymeeg (nemolizumab)Pruritus in Atopic DermatitisFiled
SculptraBody Contouring (Buttock Enhancement)Investigational
GM-2505Undisclosed Inflammatory DermatosisPhase 1

Leadership Team at Galderma

FØ
Flemming Ørnskov
Chief Executive Officer
BA
Bilal Annaim
Chief Financial Officer
BS
Baldo Scassellati Sforzolini
Global Head of Research & Development
FL
Fabrice Lefebvre
Chief Commercial Officer
View full Galderma profile